Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) is considered to be a therapeutic and prognostic marker in the management of breast carcinoma (BC), although discordance rates between primary and metastatic or locally recurrent lesions have been reported. METHODS: One hundred and forty-ei...

Descripción completa

Detalles Bibliográficos
Autores principales: Ieni, Antonio, Barresi, Valeria, Caltabiano, Rosario, Cascone, Anna Maria, Del Sordo, Rachele, Cabibi, Daniela, Zeppa, Pio, Lanzafame, Salvatore, Sidoni, Angelo, Franco, Vito, Tuccari, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103929/
https://www.ncbi.nlm.nih.gov/pubmed/25050068
http://dx.doi.org/10.2147/OTT.S65294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103929/
https://www.ncbi.nlm.nih.gov/pubmed/25050068
http://dx.doi.org/10.2147/OTT.S65294

Ejemplares similares